Allison Tronnes brings extensive expertise as a technology commercialization leader with a robust track record in driving innovation across dynamic sectors. Her career has been marked by successful ventures in integrating advanced technologies into practical applications, fostering market expansion and client engagement. As an operator focused on enhancing product development, she leverages her strategic insight to elevate operational efficiencies and optimize competitive positioning within the marketplace. Allison's collaborative approach to stakeholder relationships empowers organizations to achieve growth targets while navigating complex industry landscapes.
Allison Tronnes brings extensive expertise as a technology commercialization leader with a robust track record in driving innovation across dynamic sectors. Her career has been marked by successful ventures in integrating advanced technologies into practical applications, fostering market expansion and client engagement. As an operator focused on enhancing product development, she leverages her strategic insight to elevate operational efficiencies and optimize competitive positioning within the marketplace. Allison's collaborative approach to stakeholder relationships empowers organizations to achieve growth targets while navigating complex industry landscapes.
Allison Tronnes champions a transformative perspective on investment opportunities, particularly within the technology sector. Her deep-seated understanding of innovation and commercialization drives her approach to identifying high-potential ventures poised for disruption. Prioritizing partnerships that enhance operational capabilities, she seeks out startups with scalable business models that align with emerging market needs. By fostering synergies between innovative technologies and practical applications, she aims to unlock value across diverse ecosystems. This visionary mindset positions her as a formidable player in harnessing growth potential while navigating competitive landscapes effectively.
Allison Tronnes champions a transformative perspective on investment opportunities, particularly within the technology sector. Her deep-seated understanding of innovation and commercialization drives her approach to identifying high-potential ventures poised for disruption. Prioritizing partnerships that enhance operational capabilities, she seeks out startups with scalable business models that align with emerging market needs. By fostering synergies between innovative technologies and practical applications, she aims to unlock value across diverse ecosystems. This visionary mindset positions her as a formidable player in harnessing growth potential while navigating competitive landscapes effectively.
| Trades 10644 | Longs Won 6226/10644 58% | Profit Factor 8.54 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $4.32M |
| Average Win $426,093.85 | Best Trade (Aug 14) $366.43M | Sharpe Ratio -56.28 |
| Average Loss -$70,316.57 | Worst Trade (Sep 14) -$69.03M | Z-Score -11.34 (98.01%) |
| Commissions $0 | Avg. Trade Length 1y 7m 2w 6d | Expectancy $220,049.02 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 111,111 | 100,000 | 88,889 | 77,778 | 66,667 | 55,556 | 44,444 | 33,333 | 22,222 | 11,111 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 255,361 | $57.24M | $78.88M | - | $21.64M | 37.81% | -7.354% |
ABBV AbbVie Inc. | 54,689 | $9.12M | $13.72M | - | $4.6M | 50.49% | -2.513% |
ABEV Ambev S.A. | 11,000 | $26,730 | $34,210 | - | $7,480 | 27.98% | -0.321% |
ABT Abbott Laboratories | 45,276 | $6M | $4.79M | - | -$1.22M | -20.29% | +0.085% |
ACWX ISHARES MSCI ACWI EX U.S. ETF | 5,724 | $281,735.28 | $430,731 | - | $148,995.72 | 52.89% | -0.172% |
ADBE Adobe Inc. | 2,444 | $952,437.38 | $612,002.04 | - | -$340,435.34 | -35.74% | +1.013% |
ADI Analog Devices, Inc. | 1,407 | $323,366.2 | $516,945.87 | - | $193,579.67 | 59.86% | +0.202% |
ADP Automatic Data Processing Inc. | 2,667 | $815,496.7 | $710,648.79 | - | -$104,847.91 | -12.86% | +0.982% |
AEP American Electric Power Company, Inc. | 2,139 | $281,663.64 | $273,471.15 | - | -$8,192.49 | -2.91% | +0.055% |
AFL Aflac Inc. | 3,231 | $359,989.29 | $411,887.88 | - | $51,898.59 | 14.42% | +0.094% |
AI C3.ai Inc. | 11,531 | $223,401.66 | $105,854.58 | - | -$117,547.08 | -52.62% | +1.213% |
ALL Allstate Corporation | 10,796 | $2.23M | $2.85M | - | $622,792.82 | 27.95% | -0.49% |
AMAT Applied Materials, Inc. | 2,789 | $602,213.11 | $1.42M | - | $813,678.55 | 135.11% | +1.176% |
AMD Advanced Micro Devices, Inc. | 3,960 | $734,322.57 | $1.89M | - | $1.15M | 156.77% | -1.904% |
AMGN Amgen Inc. | 348,009 | $108.43M | $134.04M | - | $25.61M | 23.62% | -0.64% |
AMZN Amazon.com Inc | 54,657 | $11M | $14.84M | - | $3.85M | 34.97% | +15.321% |
ANET Arista Networks, Inc. | 3,292 | $559,244.96 | $593,712.23 | - | $34,467.27 | 6.16% | +5.456% |
APD Air Products and Chemicals, Inc. | 3,404 | $986,067.64 | $1M | - | $17,737.95 | 1.8% | -1.769% |
APO Apollo Global Management, Inc. | 20,923 | $2.15M | $2.63M | - | $480,539.88 | 22.38% | +4.441% |
ASML ASML Holding N.V. New York Registry Shares | 135 | $268,574.39 | $219,915 | - | -$48,659.39 | -18.12% | -1.359% |